Rep. Chip Roy, R-Texas, is demanding the FDA provide updates on the delayed abortion pill study, warning that continued delays could prompt him to push for prohibiting federal funds from supporting the 2023 removal of the in-person dispensing requirement for mifepristone.
Read →Loading search…